A multidimensional investigation of myelosuppression associated with sintilimab: integrating pharmacovigilance signal mining with real-world clinical evidence.

Front Pharmacol · 2026 · PMC13106480 · PMID 42038326

Europe PMC DOI

hedged sentence

0.0530

closest p · 1.1× alpha

0.0530

boldest claim

The sentences

marginally statistically significantP = 0.053so close (0.05 < p ≤ 0.1)

Moreover, the N stage exhibited a marginally statistically significant difference (P = 0.053), approaching the conventional significance threshold of α = 0.05.

also in 1,110 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.